New eye injection could mean fewer doctor visits for wet AMD patients
Disease control
Not yet recruiting
This study tests a new medicine called AIV007 for people with wet age-related macular degeneration (AMD), a condition that causes vision loss. About 35 participants will receive either AIV007 or a standard treatment (Eylea) as an injection around or into the eye. The goal is to s…
Phase: PHASE2 • Sponsor: AiViva BioPharma, Inc. • Aim: Disease control
Last updated May 01, 2026 16:01 UTC